Skip to main content
SpringerLink
Log in

Public Health and Prevention

  • Chapter
  • First Online:
Sexually Transmitted Diseases

Part of the book series: Current Clinical Practice ((CCP))

Abstract

Sexually transmitted diseases (STDs) are among the most commonly reported diseases in the United States, and most sexually active persons will have at least one sexually transmitted infection during their lifetime. Public health organizations at the local, state, and national levels collect information about STDs through surveillance for notifiable diseases, nationally representative studies, and special studies. Clinically, the prevention and control of STDs are based on five major strategies: education and counseling, screening, diagnosis and treatment, partner services, and vaccination. These strategies can be applied to major public health problems in STD control and prevention, including antimicrobial-resistant gonorrhea, STD-related cancers, STD-related HIV acquisition and transmission, STD-related infertility, and STD-related adverse outcomes of pregnancy. Clinicians play an important role in public health and prevention of STDs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MCB, Su J, Xu F, Weinstock H. Sexually Transmitted Infections among U.S. Women and Men: Prevalence and Incidence Estimates, 2008. Sexually Transmitted Diseases. 2013; 40(3): 187–193. [Research Support, U.S. Gov’t].

    Article  PubMed  Google Scholar 

  2. Owusu-Edusei K, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC, Kent CK. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sexually Transmitted Diseases. 2013; 40(3):197-201. [Research Support, U.S. Gov’t].

    Article  PubMed  Google Scholar 

  3. Centers for Disease Control and Prevention. Summary of notifiable diseases—United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;59(53):1–111.

    Google Scholar 

  4. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997;102(5A):3–8 [Review].

    Article  PubMed  CAS  Google Scholar 

  5. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000;151(12):1158–71 [Research Support, U.S. Gov’t, P.H.S.].

    Article  PubMed  CAS  Google Scholar 

  6. Forhan SE, Gottlieb SL, Sternberg MR, Xu F, Datta SD, McQuillan GM, et al. Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics. 2009;124(6):1505–12 [Research Support, U.S. Gov’t].

    Article  PubMed  Google Scholar 

  7. Institute of Medicine (U.S.). Committee on Prevention and Control of Sexually Transmitted Diseases, Eng TR, Butler WT. The hidden epidemic: confronting sexually transmitted diseases. Washington DC: National Academy Press; 1997.

    Google Scholar 

  8. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2010. Atlanta: U.S. Department of Health and Human Services; 2011. http://www.cdc.gov/std/stats/

    Google Scholar 

  9. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2. 1992;113:1–35.

    PubMed  Google Scholar 

  10. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59:1–110. http://www.cdc.gov/std/treatment/2010

    PubMed  Google Scholar 

  11. Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med. 2012;366(6):485–7 [Review].

    Article  PubMed  Google Scholar 

  12. Workowski KA, Berman SM, Douglas Jr JM. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. 2008;148(8):606–13 [Review].

    Article  PubMed  Google Scholar 

  13. Meyers D, Wolff T, Gregory K, Marion L, Moyer V, Nelson H, et al. USPSTF recommendations for STI screening. Am Fam Physician. 2008;77(6):819–24 [Review].

    PubMed  Google Scholar 

  14. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10 Suppl):3036–46 [Review].

    Article  PubMed  Google Scholar 

  15. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157(3):218–26 [Research Support, U.S. Gov’t].

    Article  PubMed  Google Scholar 

  16. Partridge JM, Hughes JP, Feng Q, Winer RL, Weaver BA, Xi LF, et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis. 2007;196(8):1128–36 [Research Support, N.I.H., Extramural].

    Article  PubMed  Google Scholar 

  17. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis. 2011;204(4):566–73 [Research Support, U.S. Gov’t].

    Article  PubMed  Google Scholar 

  18. Molano M, Van den Brule A, Plummer M, Weiderpass E, Posso H, Arslan A, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol. 2003;158(5):486–94 [Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  19. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132(2):277–84 [Research Support, Non-U.S. Gov’t; Research Support, U.S. Gov’t].

    Article  PubMed  CAS  Google Scholar 

  20. Paavonen J. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias. Int J Infect Dis. 2007;11 Suppl 2:S3–9 [Review].

    Article  PubMed  Google Scholar 

  21. Joseph DA, Miller JW, Wu X, Chen VW, Morris CR, Goodman MT, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer. 2008;113(10 Suppl):2892–900 [Research Support, U.S. Gov’t].

    Article  PubMed  Google Scholar 

  22. Seaberg EC, Wiley D, Martinez-Maza O, Chmiel JS, Kingsley L, Tang Y, et al. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer. 2010;116(23):5507–16 [Comparative Study Research Support, N.I.H., Extramural].

    Article  PubMed  Google Scholar 

  23. Centers for Disease Control and Prevention. Recommendations on the Use of quadrivalent human papillomavirus vaccine in males—Advisory Committee On Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60:1705–8.

    Google Scholar 

  24. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20):626–9.

    Google Scholar 

  25. Centers for Disease Control and Prevention. Progress toward implementation of human papillomavirus vaccination—the Americas, 2006–2010. MMWR Morb Mortal Wkly Rep. 2011;60(40):1382–4.

    Google Scholar 

  26. Cohen MS. Classical sexually transmitted diseases drive the spread of HIV-1: back to the future. J Infect Dis. 2012;206(1):1–2 [Review].

    Article  PubMed  Google Scholar 

  27. Hayes R, Watson-Jones D, Celum C, van de Wijgert J, Wasserheit J. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS. 2010;24 Suppl 4:S15–26 [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  28. Workowski KA, Levine WC, Wasserheit JN, Centers for Disease Control and Prevention, Atlanta, Georgia. U.S. Centers for Disease Control and Prevention guidelines for the treatment of sexually transmitted diseases: an opportunity to unify clinical and public health practice. Ann Intern Med. 2002;137(4):255–62 [Review].

    Article  PubMed  Google Scholar 

  29. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases. Sex Transm Infect. 1999;75:3–17 [Review].

    Article  PubMed  CAS  Google Scholar 

  30. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis. 2001;28:579–97 [Review].

    Article  PubMed  CAS  Google Scholar 

  31. Centers for Disease Control and Prevention. Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years—United States, 2005–2008. MMWR Morb Mortal Wkly Rep. 2010;59(15):456–9.

    Google Scholar 

  32. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis. 2007;45(10):1319–26 [Research Support, U.S. Gov’t].

    Article  PubMed  Google Scholar 

  33. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007;369(9562):657–66 [Randomized Controlled Trial].

    Article  PubMed  Google Scholar 

  34. Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, Struble KA, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005;54(RR-2):1–20 [Practice Guideline].

    PubMed  Google Scholar 

  35. Centers for Disease Control and Prevention. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60(3):65–8.

    Google Scholar 

  36. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74 [Randomized Controlled Trial; Research Support, N.I.H.; Research Support, Non-U.S. Gov’t].

    Article  PubMed  CAS  Google Scholar 

  37. Marrazzo JM, Cates W. Interventions to prevent sexually transmitted infections, including HIV infection. Clin Infect Dis. 2011;53 Suppl 3:S64–78 [Review].

    Article  PubMed  Google Scholar 

  38. Phillips DM, Sudol KM, Taylor CL, Guichard L, Elsen R, Maguire RA. Lubricants containing N-9 may enhance rectal transmission of HIV and other STIs. Contraception. 2004;70(2):107–10 [Research Support, U.S. Gov’t].

    Article  PubMed  CAS  Google Scholar 

  39. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340:c1642 [Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov’t].

    Article  PubMed  Google Scholar 

  40. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337(8):509–15.

    Article  PubMed  CAS  Google Scholar 

  41. Handel S, Klingler EJ, Washburn K, Blank S, Schillinger JA. Population-based surveillance for neonatal herpes in New York City, April 2006-September 2010. Sex Transm Dis. 2011;38(8):705–11.

    PubMed  Google Scholar 

  42. Flagg EW, Weinstock H. Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatrics. 2006;127(1):e1–8 [Research Support, U.S. Gov’t].

    Article  Google Scholar 

  43. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol. 2007;109(6):1489–98.

    Article  Google Scholar 

  44. Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med. 2009;361(14):1376–85.

    Article  PubMed  CAS  Google Scholar 

  45. Kimberlin DW, Whitley RJ, Wan W, Powell DA, Storch G, Ahmed A, et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011;365(14):1284–92.

    Article  PubMed  CAS  Google Scholar 

  46. Shah SS, Aronson PL, Mohamad Z, Lorch SA. Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics. 2011;128(6):1153–60.

    Article  PubMed  Google Scholar 

  47. Case definitions: nationally notifiable conditions infectious and non-infectious case. Atlanta, GA: Centers for Disease Control and Prevention; 2012 [cited July 11, 2012]. http://www.cdc.gov/osels/ph_surveillance/nndss/phs/infdis2011.htm

Download references

Author information

Authors and Affiliations

  1. Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA

    Elissa Meites MD, MPH, FAAFP & Kimberly A. Workowski MD, FIDSA, FACP

  2. Department of Medicine, Infectious Diseases, Emory University, Atlanta, GA, USA

    Kimberly A. Workowski MD, FIDSA, FACP

Authors
  1. Elissa Meites MD, MPH, FAAFP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kimberly A. Workowski MD, FIDSA, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elissa Meites MD, MPH, FAAFP .

Editor information

Editors and Affiliations

  1. , Family Medicine Residency Program, Abington Memorial Hospital, Old York Road 817, Jenkintown, 19046, Pennsylvania, USA

    Neil S. Skolnik

  2. Abington Family Medicine, Old York Road 817, Jenkintown, 19046, Pennsylvania, USA

    Amy Lynn Clouse

  3. East River Road 855, Tucson, 85718, Arizona, USA

    Jo Ann Woodward

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Meites, E., Workowski, K.A. (2013). Public Health and Prevention. In: Skolnik, N., Clouse, A., Woodward, J. (eds) Sexually Transmitted Diseases. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-499-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-499-9_12

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-498-2

  • Online ISBN: 978-1-62703-499-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation